Y Intercept Hong Kong Ltd Sells 20,531 Shares of Maximus, Inc. $MMS

Y Intercept Hong Kong Ltd cut its holdings in shares of Maximus, Inc. (NYSE:MMS) by 80.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 5,085 shares of the health services provider’s stock after selling 20,531 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Maximus were worth $357,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. AQR Capital Management LLC raised its position in shares of Maximus by 177.2% during the first quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider’s stock worth $79,341,000 after purchasing an additional 750,031 shares during the period. Fuller & Thaler Asset Management Inc. increased its stake in Maximus by 40.0% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider’s stock worth $117,921,000 after purchasing an additional 494,372 shares in the last quarter. Boston Partners acquired a new stake in Maximus during the 1st quarter worth approximately $20,983,000. Dimensional Fund Advisors LP raised its holdings in Maximus by 20.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider’s stock worth $115,620,000 after buying an additional 288,990 shares during the period. Finally, Nuveen LLC bought a new position in Maximus in the first quarter valued at approximately $18,586,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Maximus

In other news, insider Michelle F. Link sold 1,610 shares of the firm’s stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the transaction, the insider owned 13,508 shares in the company, valued at $1,227,336.88. This trade represents a 10.65% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 27th. Weiss Ratings raised shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, Maximus currently has an average rating of “Moderate Buy” and an average target price of $90.00.

Maximus Price Performance

NYSE MMS opened at $84.02 on Friday. The firm’s 50 day moving average is $87.40 and its 200-day moving average is $78.55. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $4.73 billion, a PE ratio of 15.47 and a beta of 0.57. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $92.63.

Maximus (NYSE:MMS) last announced its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.39 by $0.77. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm’s revenue was up 2.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.74 earnings per share. Equities research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Friday, November 14th. Maximus’s dividend payout ratio is currently 22.10%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.